Ming-Yuan Tseng
University of Cambridge
14 Papers
86 Citations
Ming-Yuan Tseng is an academic researcher from University of Cambridge. The author has contributed to research in topics: Subarachnoid hemorrhage & Vasospasm. The author has an hindex of 12, co-authored 14 publications.
Chat about Author
Papers
Effects of Acute Treatment With Pravastatin on Cerebral Vasospasm, Autoregulation, and Delayed Ischemic Deficits After Aneurysmal Subarachnoid Hemorrhage A Phase II Randomized Placebo-Controlled Trial
TL;DR: Acute treatment with pravastatin after aSAH is safe and ameliorates cerebral vasospasm, improves cerebral autoregulation, and reduces vasospasms-related DID, the first demonstration of clinical benefits with immediate statin therapy for an acute cerebrovascular disorder.
418
Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage.
Ming-Yuan Tseng,Peter J. Hutchinson,Marek Czosnyka,Hugh K. Richards,John D. Pickard,Peter J. Kirkpatrick +5 more
TL;DR: In this article, the effects of pravastatin on the frequency and intensity for rescue therapy, length of inpatient stay, and long-term outcome at 6 months were assessed.
139
Effect of Hypertonic Saline on Cerebral Blood Flow in Poor-Grade Patients With Subarachnoid Hemorrhage
TL;DR: It is found that 23.5% hypertonic saline increases CBF in poor-grade patients with subarachnoid hemorrhage and these effects are associated with improved indexes of blood rheology.
122
Enhancement of cerebral blood flow using systemic hypertonic saline therapy improves outcome in patients with poor-grade spontaneous subarachnoid hemorrhage.
Ming-Yuan Tseng,Pippa G. Al-Rawi,Marek Czosnyka,Peter J. Hutchinson,Hugh Richards,John D. Pickard,Peter J. Kirkpatrick +6 more
TL;DR: Bolus systemic hypertonic saline therapy may be used for reversal of cerebral ischemia to normal perfusion in patients with poor-grade spontaneous subarachnoid hemorrhage.
67
Effects of fluid therapy following aneurysmal subarachnoid haemorrhage: a prospective clinical study
TL;DR: Intravenous fluid therapy using synthetic colloids or blood transfusions may be associated with increased unfavourable outcome following aSAH, and Associations between synthetic colloid and crystalloids with GOS at 6 months were dose-related.
65